🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Egmidio Medina

University of California, Los Angeles

ORCID: 0000-0002-3284-5329
MedicineImmunology and MicrobiologyBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

1in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology
Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Top data-sharing exemplar

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

Supplementary Table S2 from A pilot study of neoadjuvant nivolumab, ipilimumab and intralesional oncolytic virotherapy for HER2-negative breast cancer

(2023)10.1158/2767-9764.23791808
Top 100%
0DataRank
Top 100%0 citations

Katie M. Campbell, Theodore S. Nowicki, Nila Elumalai, Egmidio Medina, Ignacio Baselga-Carretero +6 more

Papers

Driven by 16 papers — median percentile 0. Top paper: “Ipilimumab with or without nivolumab in PD-1 or PD-L1 blockade refractory metastatic melanoma: a randomized phase 2 trial”.

Ipilimumab with or without nivolumab in PD-1 or PD-L1 blockade refractory metastatic melanoma: a randomized phase 2 trial

Nature Medicine(2023)10.1038/s41591-023-02498-y
N/A
4.8DataRank · unranked
171 citations

Shay Bellasea, Kari Kendra, Nikhil I. Khushalani, Katie M. Campbell, Philip O. Scumpia +28 more

A Pilot Study of Neoadjuvant Nivolumab, Ipilimumab, and Intralesional Oncolytic Virotherapy for HER2-negative Breast Cancer

Cancer Research Communications(2023)10.1158/2767-9764.crc-23-0145
N/A
0.752DataRank · unranked
19 citations

Katie M. Campbell, Theodore S. Nowicki, Nila Elumalai, Egmidio Medina, Ignacio Baselga-Carretero +6 more

Human cancer-targeted immunity via transgenic hematopoietic stem cell progeny

Nature Communications(2025)10.1038/s41467-025-60816-z
N/A
0.281DataRank · unranked
4 citations

Nataly Naser Al Deen, Cole W. Peters, Begoña Comı́n-Anduix, Egmidio Medina, Cristina Puig-Saus +28 more

Remodeling of the Tumor Microenvironment Through PAK4 Inhibition Sensitizes Tumors to Immune Checkpoint Blockade

Cancer Research Communications(2022)10.1158/2767-9764.crc-21-0133
N/A
0DataRank · unranked
19 citations

Davis Y. Torrejon, Daniel Karin, Katie M. Campbell, Egmidio Medina, Justin D. Saco +9 more

Spatial profiling reveals association between WNT pathway activation and T-cell exclusion in acquired resistance of synovial sarcoma to NY-ESO-1 transgenic T-cell therapy

Journal for ImmunoTherapy of Cancer(2022)10.1136/jitc-2021-004190
N/A
0DataRank · unranked
10 citations

Maneesha Thaker, Egmidio Medina, Anusha Kalbasi, Arun S. Singh, Antoni Ribas +2 more

Neoantigen-targeted CD8+ T cell responses with PD-1 blockade therapy

Nature(2023)10.1038/s41586-023-05787-1
N/A
0DataRank · unranked
203 citations

Barbara Sennino, Songming Peng, Clifford L. Wang, Zheng Pan, Benjamin Yuen +51 more

Prior anti-CTLA-4 therapy impacts molecular characteristics associated with anti-PD-1 response in advanced melanoma

Cancer Cell(2023)10.1016/j.ccell.2023.03.010
N/A
0DataRank · unranked
80 citations

Meelad Amouzgar, Shannon M. Pfeiffer, Timothy R. Howes, Egmidio Medina, Michael J. Travers +14 more

Conserved Interferon-γ Signaling Drives Clinical Response to Immune Checkpoint Blockade Therapy in Melanoma

Cancer Cell(2020)10.1016/j.ccell.2020.08.005
N/A
0DataRank · unranked
389 citations

Jennifer Tsoi, Mykola Onyshchenko, Gabriel Abril-Rodríguez, Petra Ross‐Macdonald, Megan Wind‐Rotolo +31 more

Supplementary Table 5 from Remodeling of the Tumor Microenvironment Through PAK4 Inhibition Sensitizes Tumors to Immune Checkpoint Blockade

(2023)10.1158/2767-9764.22545378
N/A
0DataRank · unranked
0 citations

Davis Y. Torrejon, Daniel Karin, Katie M. Campbell, Egmidio Medina, Justin D. Saco +9 more

Supplementary Table S2 from A pilot study of neoadjuvant nivolumab, ipilimumab and intralesional oncolytic virotherapy for HER2-negative breast cancer

(2023)10.1158/2767-9764.23791808
Top 100%
0DataRank
Top 100%0 citations

Katie M. Campbell, Theodore S. Nowicki, Nila Elumalai, Egmidio Medina, Ignacio Baselga-Carretero +6 more

Data from A Pilot Study of Neoadjuvant Nivolumab, Ipilimumab, and Intralesional Oncolytic Virotherapy for HER2-negative Breast Cancer

(2023)10.1158/2767-9764.c.6762524
N/A
0DataRank · unranked
0 citations

Katie M. Campbell, Theodore S. Nowicki, Nila Elumalai, Egmidio Medina, Ignacio Baselga-Carretero +6 more

An NKG2A biased immune response confers protection for infection, autoimmune disease, and cancer

Research Square(2023)10.21203/rs.3.rs-3413673/v1
N/A
0DataRank · unranked
0 citations

Daniel Chen, Jingyi Xie, Jongchan Choi, Raymond T. Ng, Rongyu Zhang +13 more

Integrative systems biology reveals NKG2A-biased immune responses correlate with protection in infectious disease, autoimmune disease, and cancer

Cell Reports(2024)10.1016/j.celrep.2024.113872
N/A
0DataRank · unranked
12 citations

Jingyi Xie, Jongchan Choi, Raymond T. Ng, Rongyu Zhang, Sarah Li +13 more

Antitumor Immune Responses in B2M -Deficient Cancers

Cancer Immunology Research(2023)10.1158/2326-6066.cir-23-0139
N/A
0DataRank · unranked
37 citations

Mildred Galvez, Gabriel Abril-Rodríguez, Katie M. Campbell, Egmidio Medina, Agustin Vega-Crespo +4 more

Optimizing nucleic acid extraction and transcriptome evaluation from low-input, fixed clinical samples

bioRxiv (Cold Spring Harbor Laboratory)(2020)10.1101/2020.06.02.122150
N/A
0DataRank · unranked
0 citations

Egmidio Medina, Ignacio Baselga-Carretero, Yaroslav Teper, Rangasamy P. Elumalai, Raymond J. Miller +15 more

Reducing Skin Toxicities from EGFR Inhibitors with Topical BRAF Inhibitor Therapy

Cancer Discovery(2021)10.1158/2159-8290.cd-20-1847
N/A
0DataRank · unranked
25 citations

Zev A. Wainberg, Anisha B. Patel, Milan J. Anadkat, Salomon M. Stemmer, Einat Shacham‐Shmueli +5 more